Weekly Market Roundup
Biotech & Health Weekly: The Week a New Drug Class Got Approved
Thirteen years of research. One FDA approval. Arvinas crossed the finish line on May 1 with the first PROTAC therapy ever cleared by a regulator. The same day, Eli Lilly reported the most dominant quarter in GLP-1 history. A week later, Novo Nordisk answered with its own numbers. The biotech M&A machine kept running in…
Digital Assets Weekly: Wall Street Goes Onchain
Bitcoin crossed $80,000 Sunday. First time since January. The move triggered over $116 million in liquidations, nearly all of them shorts. April closed up 13% for BTC, its best month in a year. Ethereum held near $2,381. Solana at $84.79. XRP rangebound at $1.39. Prices aside, this was a week of structural decisions. Congress cleared…
Critical Minerals Weekly: Washington Acts While China Tightens Supply Chains
Copper held above $5.94 per pound on Monday, up 27.8% from this time last year and up 6.4% in just the past month. Gold sat near $4,600 per ounce, down roughly 12% since the Middle East conflict began in late February but structurally supported by central bank buying. Cobalt traded flat at $56,290 per metric…
